Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Wachtel, J. Piette, V. Mor, M. Stein, J. Fleishman, Charles Carpenter (1992)
Quality of Life in Persons with Human Immunodeficiency Virus Infection: Measurement by the Medical Outcomes Study InstrumentAnnals of Internal Medicine, 116
P. Keiser, M. Kvanli, D. Turner, J. Reisch, J. Smith, N. Nassar, C. Gregg, D. Skiest (1999)
Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration hospital.Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 20 1
R Bucciardini, AW Wu, M Floridia (2000)
Stefano Vella for the Istituto Superiore di Sanità 047 study: Quality of life outcomes of combination zidovudine-didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patientsAIDS, 14
N. Black (1996)
Why we need observational studies to evaluate the effectiveness of health careBMJ, 312
MD Carpenter, MD Cooper, MD Fischl, MD Gatell, MA Gazzard, MD Hammer, MD Hirsch, MD Jacobsen, BS Katzenstein, MD Montaner, MD Richman, M. Saag, MD Schechter, PhD Schooley, MD Thompson, MD Vella, MD Yeni, MD Volberding, MD CharlesC.J.Car-penter (2000)
Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society–USA Panel
A. Watson, M. Samore, C. Wanke (1996)
Diarrhea and quality of life in ambulatory HIV-infected patientsDigestive Diseases and Sciences, 41
C. Carpenter, M. Fischl, S. Hammer, M. Hirsch, D. Jacobsen, D. Katzenstein, J. Montaner, Richman Dd, M. Saag, R. Schooley, M. Thompson, S. Vella, P. Yeni, P. Volberding (1996)
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.JAMA, 276 2
R. Hays, W. Cunningham, C. Sherbourne, I. Wilson, A. Wu, P. Cleary, D. McCaffrey, J. Fleishman, S. Crystal, R. Collins, Ferd Eggan, M. Shapiro, S. Bozzette (2000)
Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study.The American journal of medicine, 108 9
J. Bos, L. Berg, Marten Postma (2001)
Pharmacoeconomic evaluation of intensified antiretroviral treatment strategies in HIV/AIDSExpert Review of Pharmacoeconomics & Outcomes Research, 1
E. Beck, S. Mandalia, I. Williams, A. Power, R. Newson, A. Molesworth, D. Barlow, P. Easterbrook, M. Fisher, J. Innes, G. Kinghorn, B. Mandel, A. Pozniak, A. Tang, D. Tomlinson (1999)
Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996-1997. National Prospective Monitoring System Steering Group.AIDS, 13 15
R. Bucciardini, A. Wu, M. Floridia, V. Fragola, Daniela Ricciardulli, C. Tomino, L. Weimer, M. Pirillo, M. Mirra, M. Marzi, G. Giannini, C. Galluzzo, M. Andreotti, M. Massella, S. Vella (2000)
Quality of life outcomes of combination zidovudine–didanosine–nevirapine and zidovudine–didanosine for antiretroviral-naive advanced HIV-infected patientsAIDS, 14
Deb Sherman, Douglas Fish (2000)
Management of protease inhibitor-associated diarrhea.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 30 6
H. El‐Serag, K. Olden, D. Bjorkman (2002)
Health‐related quality of life among persons with irritable bowel syndrome: a systematic reviewAlimentary Pharmacology & Therapeutics, 16
F. Snijders, J. Boer, B. Steenbergen, M. Schouten, S. Danner, F. Dam (1998)
Impact of diarrhoea and faecal incontinence on the daily life of HIV-infected patients.AIDS care, 10 5
EJ Beck, S Mandalia, I Williams (1999)
Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of antiretroviral therapy 1996–1997AIDS, 13
A Mocroft, S Vella, TL Benfield (1998)
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study GroupLancet, 352
D. Lubeck, C. Bennett, Peter Mazonson, S. Fifer, J. Fries (1993)
Quality of life and health service use among HIV-infected patients with chronic diarrhea.Journal of acquired immune deficiency syndromes, 6 5
F. Palella, K. Delaney, A. Moorman, M. Loveless, J. Fuhrer, G. Satten, D. Aschman, S. Holmberg (1998)
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.The New England journal of medicine, 338 13
W. Cunningham, M. Shapiro, Ron Hays, W. Dixon, B. Visscher, W. George, M. Ettl, C. Beck (1998)
Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease.The American journal of medicine, 104 2
E. O'Keefe, N. Talley, A. Zinsmeister, Steven Jacobsen (1995)
Bowel disorders impair functional status and quality of life in the elderly: a population-based study.The journals of gerontology. Series A, Biological sciences and medical sciences, 50 4
E. Vittinghoff, S. Scheer, P. O'Malley, G. Colfax, S. Holmberg, S. Buchbinder (1999)
Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.The Journal of infectious diseases, 179 3
RD. Moore (2000)
Cost-effectiveness of combination HIV therapy: 3 year laterPharmacoeconomics, 17
Y Mouton, S Alfandari, M Valette (1997)
Impact of protease inhibitors on AIDS-defining events and hospitalisations in 10 French AIDS reference centresAIDS, 11
A. Wu, D. Revicki, D. Jacobson, F. Malitz (1997)
Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)Quality of Life Research, 6
A. Mocroft, S. Vella, T. Benfield, A. Chiesi, V. Miller, P. Gargalianos, A. Monforte, I. Yust, JohanN. Bruun, A. Phillips, J. Lundgren (1998)
Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 352
A. Fauci, J. Bartlett, E. Goosby, M. Smith, H. Kaiser, S. Chang, Jean Anderson, R. Armstead, A. Baker, David Barr, S. Bozzette, S. Cox, M. Delaney, F. Gordin, W. Greaves, M. Harrington, J. Henning, M. Hirsch, J. Jacobs, R. Marlink, C. Maxwell, J. Mellors, D. Nash, S. Perryman, R. Schooley, R. Sherer, S. Spector, G. Torres, P. Volberding, B. Brady, E. Daniels, D. Feigal, M. Feinberg, H. Gayle, T. Graydon, J. Kaplan, A. Macher, R. Martin, H. Masur, L. Mofenson, J. Murray, J. O'Neill, L. Perez, R. Riseberg, S. Shekar, S. Stanley, J. Whitescarver (1998)
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000HIV Clinical Trials, 1
A. Wu, H. Rubin, W. Mathews, J. Ware, Lucy Brysk, W. Hardy, S. Bozzette, S. Spector, D. Richman (1991)
A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study: Preliminary Validation in Persons With Early HIV InfectionMedical Care, 29
Barbara Wise (1996)
Antiretroviral therapy in adults.Journal of the American Academy of Nurse Practitioners, 8 7
CC Carpenter, MA Fischl, SM Hammer (1997)
Antiretroviral therapy for HIV infection in 1997JAMA, 227
Diarrhea is a common symptom that many HIV patients experience either as a consequence of HIV infection or of highly active antiretroviral therapy (HAART). A multicenter, prospective observational study was conducted in 11 AIDS clinics in Italy to determine the effect of diarrhea on health-related quality of life among patients receiving HAART. The study enrolled 100 consecutive HIV positive patients who had diarrhea while on HAART. For each enrolled patient a control patient with matching disease stage who did not have diarrhea was identified using existing data from another prospective observational study conducted in 34 AIDS clinics (including the 11 in current study). Quality of life was measured by MOS-HIV Health Survey (MOS-HIV). Paired t-test and multiple regression analysis were used to compare the quality of life among patients with and without diarrhea. Mean patient age was 40 ± 7 years; 69% were male. Mean CD4 cell count was 342 ± 239 cells/mm3; 59% had AIDS. Of the cases, 49 patients had severe diarrhea ( > 5 bowel movements or > 3 watery per day) and 46 patients had moderate diarrhea (3–5 bowel movements). Compared to matched control patients, cases experiencing diarrhea while on HAART had significantly lower MOS-HIV scores in all domains. The significant adverse effect of diarrhea on quality of life should be considered when choosing the appropriate antiretroviral drugs regimen.
Quality of Life Research – Springer Journals
Published: Oct 18, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.